Gilead Sciences | Egenkapital Og Reserver

Equity Capital And Reserves Endring Dato
AbbVie USD 12.09B 772M 2023-09
Agios Pharmaceuticals USD 811.02M 75.82M 2023-12
ALKERMES USD 1.36B 75.15M 2023-09
Alnylam Pharmaceuticals USD -220644000 54.78M 2023-12
Amgen USD 6.23B 1.42B 2023-12
Eli Lilly USD 11.22B 156.6M 2023-09
Gilead Sciences USD 22.75B 435M 2023-12
GlaxoSmithKline GBP 13.13B 442M 2023-09
Incyte USD 5.19B 258.39M 2023-12
Moderna USD 13.85B 399M 2023-12
Neurocrine Biosciences USD 2B 149.1M 2023-09
Pfizer USD 96.93B 2.08B 2023-09
Regeneron Pharmaceuticals USD 25.97B 1.07B 2023-12
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
United Therapeutics USD 5.98B 272.7M 2023-12
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09



Gilead Sciences Egenkapital Og Reserver - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.